MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/eurheartj/ehp235

Медицинская библиотека · European heart journal · 2009

Early and comprehensive management of atrial fibrillation: executive summary of the proceedings from the 2nd AFNET-EHRA consensus conference 'research perspectives in AF'.

Kirchhof Paulus, Bax Jeroen, Blomstrom-Lundquist Carina, Calkins Hugh, Camm A John, Cappato Ricardo, Cosio Francisco, Crijns Harry, Diener Hans-Christian, Goette Andreas, Israel Carsten W, Kuck Karl-Heinz, Lip Gregory Y H, Nattel Stanley, Page Richard L, Ravens Ursula, Schotten Ulrich, Steinbeck Gerhard, Vardas Panos, Waldo Albert, Wegscheider Karl, Willems Stephan, Breithardt Günter

Consensus StatementСтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

Atrial fibrillation (AF) causes important mortality and morbidity on a population-level. So far, we do not have the means to prevent AF or AF-related complications adequately. Therefore, over 70 experts on atrial fibrillation convened for the 2nd AFNET/EHRA consensus conference to suggest directions for research to improve management of AF patients (Appendix 1). The group defined three main areas in need for research in AF: 1. better understanding of the mechanisms of AF; 2. Improving rhythm control monitoring and management; and 3. comprehensive cardiovascular risk management in AF patients. The group put forward the hypothesis that successful therapy of AF and its associated complications will require comprehensive therapy. This applies e.g. to the "old" debate of "rate versus rhythm control", since rhythm control is generally added to underlying (continued) rate control therapy, but also to the emerging debate of "antiarrhythmic drugs versus catheter ablation", of which both may be needed in most patients to maintain sinus rhythm, but also to therapy of conditions that predispose to AF and contribute to cardiovascular complications such as stroke, cognitive decline, heart failure, and acute coronary syndromes. We call for research initiatives aiming at a better understanding of the different causes of AF and its complications, and at development and validation of mechanism-based therapies. The future of AF therapy may require a combination of management of underlying and concomitant conditions, early and comprehensive rhythm control therapy, adequate control of ventricular rate and cardiac function, and continuous therapy to prevent AF-associated complications (e.g. antithrombotic therapy). The reasons for these suggestions are detailed in this paper.

Для цитирования: Kirchhof Paulus, Bax Jeroen, Blomstrom-Lundquist Carina, Calkins Hugh, Camm A John, Cappato Ricardo, Cosio Francisco, Crijns Harry, Diener Hans-Christian, Goette Andreas, Israel Carsten W, Kuck Karl-Heinz, Lip Gregory Y H, Nattel Stanley, Page Richard L, Ravens Ursula, Schotten Ulrich, Steinbeck Gerhard, Vardas Panos, Waldo Albert, Wegscheider Karl, Willems Stephan, Breithardt Günter. Early and comprehensive management of atrial fibrillation: executive summary of the proceedings from the 2nd AFNET-EHRA consensus conference 'research perspectives in AF'.. European heart journal. 2009. DOI: 10.1093/eurheartj/ehp235.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.